Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.

Identifieur interne : 000624 ( Main/Exploration ); précédent : 000623; suivant : 000625

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.

Auteurs : Gabriele Vargas [Brésil] ; Luiz Henrique Medeiros Geraldo [France] ; Natália Gedeão Salomão [Brésil] ; Marciano Viana Paes [Brésil] ; Flavia Regina Souza Lima [Brésil] ; Flávia Carvalho Alcantara Gomes [Brésil]

Source :

RBID : pubmed:32838339

Abstract

In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China. Since then, the World Health Organization declared a public health emergency of international concern due to a growing number of deaths around the globe, as well as unparalleled economic and sociodemographic consequences. The disease called coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel form of human coronavirus. Although coronavirus infections have been associated with neurological manifestations such as febrile seizures, convulsions, change in mental status, and encephalitis, less is known about the impact of SARS-CoV-2 in the brain. Recently, emerging evidence suggests that SARS-CoV-2 is associated with neurological alterations in COVID-19 patients with severe clinical manifestations. The molecular and cellular mechanisms involved in this process, as well as the neurotropic and neuroinvasive properties of SARS-CoV-2, are still poorly understood. Glial cells, such as astrocytes and microglia, play pivotal roles in the brain response to neuroinflammatory insults and neurodegenerative diseases. Further, accumulating evidence has shown that those cells are targets of several neurotropic viruses that severely impact their function. Glial cell dysfunctions have been associated with several neuroinflammatory diseases, suggesting that SARS-CoV-2 likely has a primary effect on these cells in addition to a secondary effect from neuronal damage. Here, we provide an overview of these data and discuss the possible implications of glial cells as targets of SARS-CoV-2. Considering the roles of microglia and astrocytes in brain inflammatory responses, we shed light on glial cells as possible drivers and potential targets of therapeutic strategies against neurological manifestations in patients with COVID-19. The main goal of this review is to highlight the need to consider glial involvement in the progression of COVID-19 and potentially include astrocytes and microglia as mediators of SARS-CoV-2-induced neurological damage.

DOI: 10.1016/j.bbih.2020.100127
PubMed: 32838339
PubMed Central: PMC7423575


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.</title>
<author>
<name sortKey="Vargas, Gabriele" sort="Vargas, Gabriele" uniqKey="Vargas G" first="Gabriele" last="Vargas">Gabriele Vargas</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Medeiros Geraldo, Luiz Henrique" sort="Medeiros Geraldo, Luiz Henrique" uniqKey="Medeiros Geraldo L" first="Luiz Henrique" last="Medeiros Geraldo">Luiz Henrique Medeiros Geraldo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Paris Cardiovascular Research Center (PARCC - INSERM U970), Université de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Cardiovascular Research Center (PARCC - INSERM U970), Université de Paris, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gedeao Salomao, Natalia" sort="Gedeao Salomao, Natalia" uniqKey="Gedeao Salomao N" first="Natália" last="Gedeão Salomão">Natália Gedeão Salomão</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Viana Paes, Marciano" sort="Viana Paes, Marciano" uniqKey="Viana Paes M" first="Marciano" last="Viana Paes">Marciano Viana Paes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Regina Souza Lima, Flavia" sort="Regina Souza Lima, Flavia" uniqKey="Regina Souza Lima F" first="Flavia" last="Regina Souza Lima">Flavia Regina Souza Lima</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Carvalho Alcantara Gomes, Flavia" sort="Carvalho Alcantara Gomes, Flavia" uniqKey="Carvalho Alcantara Gomes F" first="Flávia" last="Carvalho Alcantara Gomes">Flávia Carvalho Alcantara Gomes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32838339</idno>
<idno type="pmid">32838339</idno>
<idno type="doi">10.1016/j.bbih.2020.100127</idno>
<idno type="pmc">PMC7423575</idno>
<idno type="wicri:Area/Main/Corpus">000381</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000381</idno>
<idno type="wicri:Area/Main/Curation">000381</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000381</idno>
<idno type="wicri:Area/Main/Exploration">000381</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.</title>
<author>
<name sortKey="Vargas, Gabriele" sort="Vargas, Gabriele" uniqKey="Vargas G" first="Gabriele" last="Vargas">Gabriele Vargas</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Medeiros Geraldo, Luiz Henrique" sort="Medeiros Geraldo, Luiz Henrique" uniqKey="Medeiros Geraldo L" first="Luiz Henrique" last="Medeiros Geraldo">Luiz Henrique Medeiros Geraldo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Paris Cardiovascular Research Center (PARCC - INSERM U970), Université de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Cardiovascular Research Center (PARCC - INSERM U970), Université de Paris, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gedeao Salomao, Natalia" sort="Gedeao Salomao, Natalia" uniqKey="Gedeao Salomao N" first="Natália" last="Gedeão Salomão">Natália Gedeão Salomão</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Viana Paes, Marciano" sort="Viana Paes, Marciano" uniqKey="Viana Paes M" first="Marciano" last="Viana Paes">Marciano Viana Paes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Regina Souza Lima, Flavia" sort="Regina Souza Lima, Flavia" uniqKey="Regina Souza Lima F" first="Flavia" last="Regina Souza Lima">Flavia Regina Souza Lima</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Carvalho Alcantara Gomes, Flavia" sort="Carvalho Alcantara Gomes, Flavia" uniqKey="Carvalho Alcantara Gomes F" first="Flávia" last="Carvalho Alcantara Gomes">Flávia Carvalho Alcantara Gomes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro</wicri:regionArea>
<placeName>
<settlement type="city">Rio de Janeiro</settlement>
<region type="state">État de Rio de Janeiro</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Brain, behavior, & immunity - health</title>
<idno type="eISSN">2666-3546</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China. Since then, the World Health Organization declared a public health emergency of international concern due to a growing number of deaths around the globe, as well as unparalleled economic and sociodemographic consequences. The disease called coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel form of human coronavirus. Although coronavirus infections have been associated with neurological manifestations such as febrile seizures, convulsions, change in mental status, and encephalitis, less is known about the impact of SARS-CoV-2 in the brain. Recently, emerging evidence suggests that SARS-CoV-2 is associated with neurological alterations in COVID-19 patients with severe clinical manifestations. The molecular and cellular mechanisms involved in this process, as well as the neurotropic and neuroinvasive properties of SARS-CoV-2, are still poorly understood. Glial cells, such as astrocytes and microglia, play pivotal roles in the brain response to neuroinflammatory insults and neurodegenerative diseases. Further, accumulating evidence has shown that those cells are targets of several neurotropic viruses that severely impact their function. Glial cell dysfunctions have been associated with several neuroinflammatory diseases, suggesting that SARS-CoV-2 likely has a primary effect on these cells in addition to a secondary effect from neuronal damage. Here, we provide an overview of these data and discuss the possible implications of glial cells as targets of SARS-CoV-2. Considering the roles of microglia and astrocytes in brain inflammatory responses, we shed light on glial cells as possible drivers and potential targets of therapeutic strategies against neurological manifestations in patients with COVID-19. The main goal of this review is to highlight the need to consider glial involvement in the progression of COVID-19 and potentially include astrocytes and microglia as mediators of SARS-CoV-2-induced neurological damage.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">32838339</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2666-3546</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<PubDate>
<Year>2020</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Brain, behavior, & immunity - health</Title>
<ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.</ArticleTitle>
<Pagination>
<MedlinePgn>100127</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2020.100127</ELocationID>
<Abstract>
<AbstractText>In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China. Since then, the World Health Organization declared a public health emergency of international concern due to a growing number of deaths around the globe, as well as unparalleled economic and sociodemographic consequences. The disease called coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel form of human coronavirus. Although coronavirus infections have been associated with neurological manifestations such as febrile seizures, convulsions, change in mental status, and encephalitis, less is known about the impact of SARS-CoV-2 in the brain. Recently, emerging evidence suggests that SARS-CoV-2 is associated with neurological alterations in COVID-19 patients with severe clinical manifestations. The molecular and cellular mechanisms involved in this process, as well as the neurotropic and neuroinvasive properties of SARS-CoV-2, are still poorly understood. Glial cells, such as astrocytes and microglia, play pivotal roles in the brain response to neuroinflammatory insults and neurodegenerative diseases. Further, accumulating evidence has shown that those cells are targets of several neurotropic viruses that severely impact their function. Glial cell dysfunctions have been associated with several neuroinflammatory diseases, suggesting that SARS-CoV-2 likely has a primary effect on these cells in addition to a secondary effect from neuronal damage. Here, we provide an overview of these data and discuss the possible implications of glial cells as targets of SARS-CoV-2. Considering the roles of microglia and astrocytes in brain inflammatory responses, we shed light on glial cells as possible drivers and potential targets of therapeutic strategies against neurological manifestations in patients with COVID-19. The main goal of this review is to highlight the need to consider glial involvement in the progression of COVID-19 and potentially include astrocytes and microglia as mediators of SARS-CoV-2-induced neurological damage.</AbstractText>
<CopyrightInformation>© 2020 The Authors.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vargas</LastName>
<ForeName>Gabriele</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Medeiros Geraldo</LastName>
<ForeName>Luiz Henrique</ForeName>
<Initials>LH</Initials>
<AffiliationInfo>
<Affiliation>Paris Cardiovascular Research Center (PARCC - INSERM U970), Université de Paris, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gedeão Salomão</LastName>
<ForeName>Natália</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Viana Paes</LastName>
<ForeName>Marciano</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Regina Souza Lima</LastName>
<ForeName>Flavia</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carvalho Alcantara Gomes</LastName>
<ForeName>Flávia</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Brain Behav Immun Health</MedlineTA>
<NlmUniqueID>101759062</NlmUniqueID>
<ISSNLinking>2666-3546</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Astrocyte</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Glial cells</Keyword>
<Keyword MajorTopicYN="N">Microglia</Keyword>
<Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
</KeywordList>
<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>06</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>08</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>08</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32838339</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbih.2020.100127</ArticleId>
<ArticleId IdType="pii">S2666-3546(20)30092-2</ArticleId>
<ArticleId IdType="pii">100127</ArticleId>
<ArticleId IdType="pmc">PMC7423575</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList>
<Reference>
<Citation>J Clin Neurol. 2017 Jul;13(3):227-233</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28748673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):514-523</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2020 Apr 7;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32265513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):889-890</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32215618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Psychiatry. 2019 Oct 03;10:712</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31632307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Chem Neurosci. 2020 May 6;11(9):1200-1203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32283006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Case Rep Neurol Med. 2016;2016:3502683</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27239356</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1995 Feb;69(2):633-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7815526</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 2019 May;149(4):518-534</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30556910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Aug;72(8):6511-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9658094</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2016 Mar 10;374(10):951-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26862926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Alzheimers Dis. 2020;76(1):3-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32538857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Rev. 2018 Jan 1;98(1):239-389</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29351512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2020 Sep;69(9):1857-1863</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32669390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropathol Appl Neurobiol. 2013 Feb;39(1):19-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23039106</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Cell Neurosci. 2015 Feb 02;9:28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25698933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chemotherapy. 2019;64(5-6):215-223</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32259829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Jun 23;11(6):e0157786</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27336851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Intensive Care. 2016 Mar 23;4:18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27011789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 1988 Mar 15;140(6):2068-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2831279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2018 Jan;55(1):751-762</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28050794</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Oct;74(19):8913-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10982334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Aging Neurosci. 2015 Jul 20;7:124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26257642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Neurosci. 2018 Feb 20;19(1):5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29463209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2020 Jun 13;12(11):10035-10040</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32534451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Geroscience. 2020 Aug;42(4):1083-1087</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32451846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 2;395(10234):1417-1418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32325026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurochem Int. 2016 May;95:85-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26845377</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mult Scler. 2019 Mar;25(3):427-430</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30226115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Aug;82(15):7264-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18495771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 2000 Aug 1;108(1-2):73-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10900340</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2006;581:543-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17037595</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 May;79(10):6102-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15857995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 Apr 05;18(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28379162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Jul 17;369(6501):256-257</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32675364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurovirol. 2017 Jun;23(3):394-403</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28116674</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Aging Neurosci. 2019 Mar 19;11:59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30941031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2015 Dec 16;90(5):2586-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26676788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2017 Jul 12;37(28):6797-6809</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28607171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gut. 2020 Jun;69(6):1002-1009</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32213556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2005 Oct 15;41(8):1089-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16163626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(7):3398-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15016862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Pathol. 2008 Jan;18(1):40-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17935605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anaesthesiol Intensive Ther. 2020;52(2):132-138</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32419438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2016 Mar 1;213(5):712-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26486634</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mov Disord. 2020 May;35(5):716-720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32291797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2019 Nov 29;9(1):17926</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31784616</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2018 Dec 20;9:3022</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30619363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurotox Res. 2020 Jun;38(1):1-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32399719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2011 Nov 9;31(45):16064-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22072657</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2020 Jun 16;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32546655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jul;92(7):703-704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32352575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ Open Diabetes Res Care. 2020 Apr;8(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32345579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 2009 Aug;66(2):253-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19743454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glia. 2014 Dec;62(12):1917-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25042347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 Nov 5;330(6005):841-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20966214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Nov 30;287(49):41432-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23055518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2019 Jun 26;10:1435</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31293558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Laryngoscope. 2020 Jul;130(7):1787</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32237238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1992;122(1-2):35-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1309644</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2017 Jan 10;18(2):557-570</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28076797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Neurosci. 2009 Dec;32(12):638-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19782411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1995 Nov 10;213(2):482-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7491773</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care. 2020 Apr 28;24(1):176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32345343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2008 Oct;4(7):963-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18772620</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Psychiatry. 2020 Jul;7(7):611-627</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32437679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2018 Jan 2;22(1):269-285</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29298427</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2020 May 31;12(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32486462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1997;142(5):1011-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9191865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2018 Aug 16;92(17):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29925652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2018 May 16;9:1018</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29867903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1985 Mar;53(3):1016-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3973963</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Virus Res. 2011;81:85-164</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22094080</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Gerontol. 2016 Oct;83:71-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27466072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 4;382(23):2268-2270</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Glia. 2020 May 25;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32449994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jan;81(2):813-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17079315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2019 Apr 02;11(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30986974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 2019 Dec;151(6):676-688</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31478208</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2017 Jan 14;14(1):8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28088249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Microbiol. 2016 Jun;24(6):490-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27012512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2009 Nov;31(10):731-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19114298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Neurol. 2020 Jul 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32668062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine X. 2020 Jun;2(2):100029</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32421092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 2014 Feb;49:96-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24290367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22390970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Feb 27;375(9716):773-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20189029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1896-E1905</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29437957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2019 Dec 1;203(11):2979-2989</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31619539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32286245</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2018 Mar 1;128(3):931-943</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29376888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32350134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2015 Jul 27;212(8):1153-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26122661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Jun 09;6:27670</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27279150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2020 Jul;87:18-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32240762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autoimmun Rev. 2020 Jun;19(6):102537</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32251717</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Neuroanat. 2020 Jun 16;14:37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32612515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Pathol. 2018 Jan 24;13:379-394</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29195051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 2019 Apr 26;37:73-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31026414</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Neurol Neurosurg. 2020 Jul;194:105921</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32422545</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neuropathol. 2018 Sep;136(3):461-482</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30027450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2010 Apr;91(Pt 4):1028-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20007359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2020 Mar 27;11(1):1620</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32221306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Mol Pathol. 2020 Aug;115:104474</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32454103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Elife. 2019 Jul 16;8:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31309928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2020 Feb 4;30(5):1271-1281</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32023447</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine Growth Factor Rev. 2020 Jun;53:25-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32446778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2020 Mar;48(3):353-361</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31770149</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Mar;87(5):2814-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23269784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2019;16(4):291-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31633476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Leukoc Biol. 2008 Oct;84(4):932-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18495785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acad Radiol. 2020 Jun;27(6):892-893</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32295727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Oct;81(20):10933-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17670819</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32192578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Apr;92(4):448-454</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31997390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Neurol. 2020 Apr 10;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32275288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2019 Jul;56(7):4653-4679</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30377983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2003 Oct 10;315(1):20-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14592756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 1998;440:575-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9782332</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2015 Aug;52(1):653-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25257696</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2018 Aug;55(8):6558-6571</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29327203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2003 Nov 10;316(1):104-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14599795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Nov 25;355(2):152-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16908043</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Physiol (Oxf). 2020 Jul;229(3):e13473</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32223077</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Jul;583(7816):459-468</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32353859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2006 Jul;87(Pt 7):1953-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16760397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurovirol. 1998 Aug;4(4):465-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9718141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2020 Jan 27;10(1):1218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31988337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Neurosci. 2019 Aug;22(8):1276-1288</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31235930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Cell. 2011 Apr;10(2):263-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21108733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 2020 May 21;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32438456</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Pathol. 2003 Apr;13(2):211-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12744474</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Brésil</li>
<li>France</li>
</country>
<region>
<li>État de Rio de Janeiro</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
<li>Rio de Janeiro</li>
</settlement>
</list>
<tree>
<country name="Brésil">
<region name="État de Rio de Janeiro">
<name sortKey="Vargas, Gabriele" sort="Vargas, Gabriele" uniqKey="Vargas G" first="Gabriele" last="Vargas">Gabriele Vargas</name>
</region>
<name sortKey="Carvalho Alcantara Gomes, Flavia" sort="Carvalho Alcantara Gomes, Flavia" uniqKey="Carvalho Alcantara Gomes F" first="Flávia" last="Carvalho Alcantara Gomes">Flávia Carvalho Alcantara Gomes</name>
<name sortKey="Gedeao Salomao, Natalia" sort="Gedeao Salomao, Natalia" uniqKey="Gedeao Salomao N" first="Natália" last="Gedeão Salomão">Natália Gedeão Salomão</name>
<name sortKey="Regina Souza Lima, Flavia" sort="Regina Souza Lima, Flavia" uniqKey="Regina Souza Lima F" first="Flavia" last="Regina Souza Lima">Flavia Regina Souza Lima</name>
<name sortKey="Viana Paes, Marciano" sort="Viana Paes, Marciano" uniqKey="Viana Paes M" first="Marciano" last="Viana Paes">Marciano Viana Paes</name>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Medeiros Geraldo, Luiz Henrique" sort="Medeiros Geraldo, Luiz Henrique" uniqKey="Medeiros Geraldo L" first="Luiz Henrique" last="Medeiros Geraldo">Luiz Henrique Medeiros Geraldo</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000624 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000624 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32838339
   |texte=   Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32838339" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021